Axion Capital Management is a boutique asset management firm offering alternative investment opportunities and wealth management services to institutions and high net worth individuals.
Our hedge fund, Axion Long-Short Fund, LP was launched in January of 2013.
Besides managing an absolute return fund, Axion Capital Management also has extensive experience in the private equity space. Over the years our firm has funded unique opportunities in technology and life sciences. Most recently, we were the lead investor in AmpliMed Corporation, a biotech drug discovery company founded by renowned oncologists, which currently has multiple drugs in late stage clinical trials.
In addition, Axion Capital Management offers private wealth management services for high net worth individuals seeking long term capital appreciation.